Bruderman Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-531
Closed -$69K 357
2019
Q1
$69K Buy
531
+2
+0.4% +$243 0.02% 231
2018
Q4
$61K Buy
529
+495
+1,456% +$55.3K 0.02% 221
2018
Q3
$4K Hold
34
﹤0.01% 315
2018
Q2
$3K Buy
34
+1
+3% +$82 ﹤0.01% 340
2018
Q1
$3K Buy
+33
New +$2.66K ﹤0.01% 328
2016
Q4
Sell
-115
Closed -$9K 382
2016
Q3
$9K Buy
115
+1
+0.9% +$80 ﹤0.01% 336
2016
Q2
$9K Sell
114
-108
-49% -$8.13K ﹤0.01% 315
2016
Q1
$16K Sell
222
-6,068
-96% -$459K 0.01% 288
2015
Q4
$530K Sell
6,290
-2,144
-25% -$178K 0.2% 71
2015
Q3
$706K Sell
8,434
-823
-9% -$69.5K 0.28% 60
2015
Q2
$773K Sell
9,257
-23,545
-72% -$1.79M 0.3% 60
2015
Q1
$2.38M Buy
+32,802
New +$2.34M 0.93% 26

Other funds holding LLY

Bruderman Asset Management's LLY Position: Q2 2019 in Review

Bruderman Asset Management sold out of Eli Lilly (LLY) in Q2 2019, closing a stake of 531 shares — an estimated $69K sold.

Bruderman Asset Management first reported a position in LLY in Q1 2015 and held it in 12 quarters. The position peaked at $2.38M in Q1 2015. 1,516 funds tracked by Wall St. Rank hold LLY as of Q2 2019.

  • Bruderman Asset Management reported no remaining Eli Lilly position as of Q2 2019 after selling out during the quarter.
  • Bruderman Asset Management sold 531 Eli Lilly shares in Q2 2019, an estimated $69K.
  • Bruderman Asset Management first reported a position in Eli Lilly in Q1 2015 and held it in 12 quarters.
  • Bruderman Asset Management's Eli Lilly position peaked at $2.38M in Q1 2015.
  • 1,516 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2019.

Based on Bruderman Asset Management's 13F filing for Q2 2019, filed 12 Aug 2019.